Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan
<i>Background</i>: Aspirin use has been associated with improved survival rates in various cancers. However, it remains unclear if aspirin confers a survival benefit on patients with nasopharyngeal carcinoma (NPC). The aim of this study was to assess the associations between aspirin use...
Main Authors: | Sheng-Dean Luo, Wei-Chih Chen, Ching-Nung Wu, Yao-Hsu Yang, Shau-Hsuan Li, Fu-Min Fang, Tai-Lin Huang, Yu-Ming Wang, Tai-Jan Chiu, Shao-Chun Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1551 |
Similar Items
-
Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study
by: Sun XS, et al.
Published: (2019-09-01) -
Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort
by: Xue‐Song Sun, et al.
Published: (2019-08-01) -
Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis
by: Tao Y, et al.
Published: (2018-08-01) -
Relation between type of hysterectomy and survival rate in patients with ovarian cancer – single-center study
by: Stanislav Slavchev, et al.
Published: (2020-10-01) -
Development and validation of a risk prediction score for patients with nasopharyngeal carcinoma
by: Ning Xue, et al.
Published: (2021-08-01)